
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16518712
[patent_doc_number] => 10869914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Methods of treating abnormalities of the first metatarsophalangeal joint of the foot
[patent_app_type] => utility
[patent_app_number] => 16/734251
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10213
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734251 | Methods of treating abnormalities of the first metatarsophalangeal joint of the foot | Jan 2, 2020 | Issued |
Array
(
[id] => 17460664
[patent_doc_number] => 20220073969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => USE OF SIDEROMYCINS TO LIMIT CROSS-REACTIVITY AND IMPROVE SPECIES IDENTIFICATION IN ANTIBIOTIC SUSCEPTIBILITY ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/418038
[patent_app_country] => US
[patent_app_date] => 2019-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418038 | USE OF SIDEROMYCINS TO LIMIT CROSS-REACTIVITY AND IMPROVE SPECIES IDENTIFICATION IN ANTIBIOTIC SUSCEPTIBILITY ASSAYS | Dec 21, 2019 | Abandoned |
Array
(
[id] => 17398191
[patent_doc_number] => 20220040281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => RNA FOR MALARIA VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/416731
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416731 | RNA FOR MALARIA VACCINES | Dec 19, 2019 | Abandoned |
Array
(
[id] => 18354021
[patent_doc_number] => 11642406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Compositions comprising
[patent_app_type] => utility
[patent_app_number] => 16/717509
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 53366
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717509 | Compositions comprising | Dec 16, 2019 | Issued |
Array
(
[id] => 17443721
[patent_doc_number] => 20220064226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Panel comprising Borrelia MHC multimers
[patent_app_type] => utility
[patent_app_number] => 17/415077
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415077
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415077 | Panel comprising | Dec 16, 2019 | Issued |
Array
(
[id] => 15963737
[patent_doc_number] => 20200165620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY
[patent_app_type] => utility
[patent_app_number] => 16/704032
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704032
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704032 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Dec 4, 2019 | Issued |
Array
(
[id] => 16607159
[patent_doc_number] => 10908160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Method for detecting
[patent_app_type] => utility
[patent_app_number] => 16/701895
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9722
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16701895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/701895 | Method for detecting | Dec 2, 2019 | Issued |
Array
(
[id] => 17426907
[patent_doc_number] => 20220054615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PERTUSSIS BOOSTER VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/299244
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299244 | PERTUSSIS BOOSTER VACCINE | Nov 28, 2019 | Abandoned |
Array
(
[id] => 15797287
[patent_doc_number] => 20200121786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => MODIFIED LIPOPOLYSACCHARIDE GLYCOFORM AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 16/690739
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/690739 | Modified lipopolysaccharide glycoform and method of use | Nov 20, 2019 | Issued |
Array
(
[id] => 17336405
[patent_doc_number] => 20220002736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/294215
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294215 | ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS | Nov 14, 2019 | Abandoned |
Array
(
[id] => 16800214
[patent_doc_number] => 10995135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/681926
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8410
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681926
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681926 | None | Nov 12, 2019 | Issued |
Array
(
[id] => 17334677
[patent_doc_number] => 20220001008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => LIVE SELF-DESTRUCTING BACTERIAL ADJUVANTS TO ENHANCE INDUCTION OF IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/291480
[patent_app_country] => US
[patent_app_date] => 2019-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291480 | Live self-destructing bacterial adjuvants to enhance induction of immunity | Nov 3, 2019 | Issued |
Array
(
[id] => 15621153
[patent_doc_number] => 20200080981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => POTENCY TEST FOR VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/670513
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670513 | Ready to use porcine vaccine | Oct 30, 2019 | Issued |
Array
(
[id] => 17164152
[patent_doc_number] => 11150244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Apparatus and method for detecting microbial contamination
[patent_app_type] => utility
[patent_app_number] => 16/671022
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9927
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/671022 | Apparatus and method for detecting microbial contamination | Oct 30, 2019 | Issued |
Array
(
[id] => 17519320
[patent_doc_number] => 20220105168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/309067
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309067 | Gut bacteria derived microvesicles for vaccine delivery | Oct 21, 2019 | Issued |
Array
(
[id] => 17532422
[patent_doc_number] => 20220111031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Vaccines targeting M. catharrhalis
[patent_app_type] => utility
[patent_app_number] => 17/287580
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287580 | Vaccines targeting M. catharrhalis | Oct 21, 2019 | Abandoned |
Array
(
[id] => 17300794
[patent_doc_number] => 20210396633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHOD FOR RECOVERING EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/284963
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284963 | Method for recovering extracellular vesicles | Oct 15, 2019 | Issued |
Array
(
[id] => 17300794
[patent_doc_number] => 20210396633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHOD FOR RECOVERING EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/284963
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284963 | Method for recovering extracellular vesicles | Oct 15, 2019 | Issued |
Array
(
[id] => 19763332
[patent_doc_number] => 12221611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Astrocyte-specific nucleic acid aptamer and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/285351
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 11083
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285351 | Astrocyte-specific nucleic acid aptamer and use thereof | Oct 14, 2019 | Issued |
Array
(
[id] => 16108507
[patent_doc_number] => 20200206276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/597673
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597673 | Compositions comprising bacterial strains | Oct 8, 2019 | Issued |